Tempest Therapeutics Inc is a clinical-stage biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Tempest Therapeutics Inc is a clinical-stage biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity.
BRISBANE, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated...
BRISBANE, Calif., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0165 | 1.83844011142 | 0.8975 | 1.01 | 0.852 | 818989 | 0.92567458 | CS |
4 | 0.083 | 9.98796630566 | 0.831 | 1.05 | 0.792 | 1363632 | 0.93676528 | CS |
12 | -0.0818 | -8.2145009038 | 0.9958 | 1.16 | 0.6986 | 1632849 | 0.90731451 | CS |
26 | -0.766 | -45.5952380952 | 1.68 | 2.18 | 0.6986 | 3126556 | 1.19101806 | CS |
52 | -2.816 | -75.4959785523 | 3.73 | 6 | 0.6986 | 2047529 | 1.69085924 | CS |
156 | -2.796 | -75.3638814016 | 3.71 | 9.77 | 0.17 | 1702797 | 4.17117615 | CS |
260 | -12.896 | -93.3816075308 | 13.81 | 41 | 0.17 | 1468041 | 4.67272482 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.